Merrimack Pharmaceuticals, Inc. (MACK) financial statements (2021 and earlier)

Company profile

Business Address ONE BROADWAY
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:1417719322186124
Cash and cash equivalents141720932218636
Short-term investments  51   88
Other undisclosed cash, cash equivalents, and short-term investments(0)00    
Restricted cash and investments  10000
Receivables   01763
Inventory, net of allowances, customer advances and progress billings    154 
Inventory    154 
Other undisclosed current assets3241455
Total current assets:1719769557201132
Noncurrent Assets
Property, plant and equipment  26162215
Long-term investments and receivables  711   
Long-term investments  711   
Intangible assets, net (including goodwill)    81111
Goodwill    444
Intangible assets, net (excluding goodwill)    478
Restricted cash and investments   1111
Other noncurrent assets0135000
Total noncurrent assets:011222243327
TOTAL ASSETS:17208911781235159
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:131418505237
Accounts payable0013353
Accrued liabilities0026161417
Employee-related liabilities  23996
Taxes payable  0    
Interest and dividends payable   0233
Other undisclosed accounts payable and accrued liabilities028620218
Debt      13
Deferred rent credit  1
Deferred revenue and credits2385261
Other liabilities 0     
Total current liabilities:13152088104111
Noncurrent Liabilities
Long-term debt and lease obligation  15 217258107
Long-term debt, excluding current maturities  15 217258107
Liabilities, other than long-term debt  01295641
Deferred revenue and credits1295641
Other liabilities  00   
Other undisclosed noncurrent liabilities     12
Total noncurrent liabilities:  151246315150
Total liabilities:133021334419261
Stockholders' equity
Stockholders' equity attributable to parent16175996(251)(184)(102)
Common stock1111111
Additional paid in capital558557581578702617552
Accumulated other comprehensive loss  (0)   (0)
Accumulated deficit(544)(541)(523)(483)(955)(802)(655)
Stockholders' equity attributable to noncontrolling interest    (2)00
Total stockholders' equity:16175996(253)(184)(102)
TOTAL LIABILITIES AND EQUITY:17208911781235159

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues 5 214489103
Revenue, net 14489 
Gain on disposition of assets for financial service operations 5 
Financial services revenue2   
Cost of revenue    (7)(0) 
Gross profit: 5 213789103
Operating expenses(3)(22)(66)(105)(248)(219)(169)
Other undisclosed operating income (loss) (5) 8  0
Operating loss:(3)(22)(66)(96)(110)(130)(66)
Nonoperating income (expense)(0)(0)(3)10011
Investment income, nonoperating01112000
Other nonoperating income (expense)(0)0(3)(1)(0)11
Interest and debt expense (1)(1)(35)(44)(19)(18)
Loss from continuing operations before equity method investments, income taxes:(3)(24)(69)(120)(154)(148)(84)
Other undisclosed income from continuing operations before income taxes 112   
Loss from continuing operations before income taxes:(3)(23)(68)(118)(154)(148)(84)
Income tax expense (benefit)(0)1842   
Loss from continuing operations:(3)(21)(61)(76)(154)(148)(84)
Income from discontinued operations 420547   
Net income (loss):(3)(17)(41)471(154)(148)(84)
Net income (loss) attributable to noncontrolling interest   12(0)0
Net income (loss) available to common stockholders, diluted:(3)(17)(41)472(152)(148)(83)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(3)(17)(41)471(154)(148)(84)
Comprehensive income (loss):(3)(17)(41)471(154)(148)(84)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest   12(0)0
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 0(0)  0(0)
Comprehensive income (loss), net of tax, attributable to parent:(3)(17)(41)472(152)(148)(83)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: